BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24308521)

  • 1. Monitoring the size and protagonists of the drug market: combining supply and demand data sources and estimates.
    Rossi C
    Curr Drug Abuse Rev; 2013 Jun; 6(2):122-9. PubMed ID: 24308521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two ways of estimating the euro value of the illicit market for cannabis in France.
    Legleye S; Ben Lakhdar C; Spilka S
    Drug Alcohol Rev; 2008 Sep; 27(5):466-72. PubMed ID: 18696293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cocaine and heroin markets in the era of globalisation and drug reduction policies.
    Costa Storti C; De Grauwe P
    Int J Drug Policy; 2009 Nov; 20(6):488-96. PubMed ID: 19447024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the dollar value of the illicit market for cannabis in New Zealand.
    Wilkins C; Reilly JL; Pledger M; Casswell S
    Drug Alcohol Rev; 2005 May; 24(3):227-34. PubMed ID: 16096126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demand for illicit drugs among pregnant women.
    Corman H; Noonan K; Reichman NE; Dave D
    Adv Health Econ Health Serv Res; 2005; 16():41-60. PubMed ID: 17867234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Demand Responses to Illegal Drug Supply Interdictions.
    Cunningham S; Finlay K
    Health Econ; 2016 Oct; 25(10):1268-90. PubMed ID: 26216390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
    Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
    Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
    Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
    Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the structure and operation of drug supply chains: The case of cocaine and heroin in Italy and Slovenia.
    Caulkins JP; Disley E; Tzvetkova M; Pardal M; Shah H; Zhang X
    Int J Drug Policy; 2016 May; 31():64-73. PubMed ID: 26997542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The socioeconomic impact of drug-related crimes in Chile.
    Fernández M
    Int J Drug Policy; 2012 Nov; 23(6):465-72. PubMed ID: 22608568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 'demand side' estimate of the dollar value of the cannabis black market in New Zealand.
    Wilkins C; Bhatta K; Casswell S
    Drug Alcohol Rev; 2002 Jun; 21(2):145-51. PubMed ID: 12188993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safer scoring? Cryptomarkets, social supply and drug market violence.
    Barratt MJ; Ferris JA; Winstock AR
    Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia.
    Chalmers J; Bradford D; Jones C
    Int J Drug Policy; 2010 Sep; 21(5):381-9. PubMed ID: 20619627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
    Aldridge J; Askew R
    Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of drug use and abuse.
    Maynard A
    Ciba Found Symp; 1992; 166():242-51; discussion 251-60. PubMed ID: 1638917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling and policing substance use(rs).
    White T
    Subst Use Misuse; 2002; 37(8-10):973-83. PubMed ID: 12180573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
    Aldridge J; Décary-Hétu D
    Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doctors not well served by their illicit drug policy.
    Weatherburn D
    Intern Med J; 2005 May; 35(5):312-3; author reply 313-4. PubMed ID: 15845123
    [No Abstract]   [Full Text] [Related]  

  • 19. Yet another dimension of the ineffectiveness of supply-side interventions in illegal drug markets.
    Mejia D
    Addiction; 2014 Dec; 109(12):1968-9. PubMed ID: 25384930
    [No Abstract]   [Full Text] [Related]  

  • 20. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.